等待开盘 06-03 09:30:00 美东时间
-0.090
-5.08%
PMGC Holdings shares gained in premarket trading after the company acquired A&B Aerospace in a $4.5 million aerospace manufacturing deal.
05-13 20:42
SVM Machining, Inc. (d/b/a Silicon Valley Manufacturing) ("SVM"), an ISO 9001:2015 certified precision CNC machining company and wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB), today announced the execution
04-21 19:32
NorthStrive Biosciences Inc. ("NorthStrive Biosciences"), a wholly owned subsidiary of PMGC Holdings Inc. ("PMGC" or the "Company") (NASDAQ:ELAB), today announced a key development milestone for its asset, EL-32: the
04-13 19:37
US stocks traded lower on Thursday, with the Nasdaq falling 1%. Energy shares rose, while consumer discretionary stocks fell. US jobless claims declined.
04-02 22:44
US stocks up, Dow gains 200 points, NASDAQ slightly up. Utilities rise, industrials fall. Americas Gold and Silver Corp shares down 13% after earnings.
03-30 22:25
NTGR: 16% | Netgear shares are trading higher after the FCC added internet routers made in foreign countries to its covered list of prohibited products. ELAB: 55% | PMGC Holdings' Subsidiary, SVM
03-24 19:25
NorthStrive Biosciences Inc. ("NorthStrive"), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB) (the "Company," "PMGC," "we," or "our"), today announced that it has executed a definitive, exclusive license
02-11 20:33
PMGC Holdings Inc. (NASDAQ:ELAB) ("PMGC," the "Company," "we," or "our") today announced that its wholly owned subsidiary, AGA Precision Systems LLC ("AGA"), successfully achieved AS9100 certification, the globally
2025-12-22 20:38
PMGC Capital urge Alaunos Therapeutics to accept a Wall Street bank-backed financing offer, calling it a strategic opportunity to create value for shareholders.
2025-06-18 13:52
Northstrive Biosciences and Yuva Biosciences have launched Phase II of their AI Development Program, utilizing MitoNova™ to identify small molecule candidates that enhance mitochondrial health in obesity and cardiac diseases. This collaboration aims to develop innovative pharmaceutical treatments for related conditions.
2025-06-17 13:04